Resources Management Corp CT ADV bought a new stake in UnitedHealth Group Inc (NYSE:UNH) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 12,280 shares of the healthcare conglomerate’s stock, valued at approximately $2,669,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Northern Trust Corp raised its stake in UnitedHealth Group by 0.4% in the second quarter. Northern Trust Corp now owns 12,111,540 shares of the healthcare conglomerate’s stock valued at $2,955,336,000 after buying an additional 53,710 shares during the period. Nuveen Asset Management LLC raised its stake in UnitedHealth Group by 1,354.6% in the 2nd quarter. Nuveen Asset Management LLC now owns 8,540,562 shares of the healthcare conglomerate’s stock valued at $2,083,983,000 after acquiring an additional 7,953,416 shares during the period. Janus Henderson Group PLC raised its stake in UnitedHealth Group by 16.7% in the 2nd quarter. Janus Henderson Group PLC now owns 6,448,289 shares of the healthcare conglomerate’s stock valued at $1,573,438,000 after acquiring an additional 922,290 shares during the period. Viking Global Investors LP lifted its holdings in UnitedHealth Group by 28.6% during the 2nd quarter. Viking Global Investors LP now owns 4,812,185 shares of the healthcare conglomerate’s stock valued at $1,174,221,000 after purchasing an additional 1,071,149 shares during the last quarter. Finally, Longview Partners Guernsey LTD lifted its holdings in UnitedHealth Group by 9.9% during the 2nd quarter. Longview Partners Guernsey LTD now owns 3,752,630 shares of the healthcare conglomerate’s stock valued at $915,679,000 after purchasing an additional 338,097 shares during the last quarter. Institutional investors and hedge funds own 85.50% of the company’s stock.
UNH has been the topic of several research reports. Jefferies Financial Group downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and decreased their price objective for the company from $300.00 to $235.00 in a report on Thursday, October 10th. Mizuho restated a “buy” rating and set a $300.00 target price (up previously from $270.00) on shares of UnitedHealth Group in a research note on Tuesday, November 26th. Credit Suisse Group restated an “outperform” rating and set a $320.00 target price (up previously from $293.00) on shares of UnitedHealth Group in a research note on Wednesday. UBS Group lifted their target price on shares of UnitedHealth Group from $257.00 to $279.00 and gave the stock a “neutral” rating in a report on Wednesday. Finally, SunTrust Banks reiterated a “buy” rating and issued a $335.00 price target (up previously from $310.00) on shares of UnitedHealth Group in a research note on Monday, November 18th. Six equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and an average target price of $298.35.
NYSE:UNH traded up $2.42 during mid-day trading on Wednesday, reaching $279.32. 2,674,020 shares of the company’s stock were exchanged, compared to its average volume of 3,479,326. UnitedHealth Group Inc has a one year low of $208.07 and a one year high of $287.94. The firm has a market capitalization of $264.70 billion, a PE ratio of 21.69, a price-to-earnings-growth ratio of 1.48 and a beta of 0.64. The business’s fifty day simple moving average is $259.15 and its two-hundred day simple moving average is $245.54. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.70.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.75 by $0.13. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The firm had revenue of $60.35 billion during the quarter, compared to the consensus estimate of $59.84 billion. During the same quarter in the previous year, the firm posted $3.41 EPS. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. As a group, equities research analysts forecast that UnitedHealth Group Inc will post 14.96 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $1.08 dividend. This represents a $4.32 annualized dividend and a dividend yield of 1.55%. The ex-dividend date of this dividend is Friday, December 6th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.54%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: How can investors invest in the Euro STOXX 50 Index?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.